Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, 100142, People's Republic of China.
College of Life Sciences and Bioengineering, School of Science, Beijing Jiaotong University, 3 Shangyuancun, Haidian District, Beijing, 100044, People's Republic of China.
Gastric Cancer. 2019 Sep;22(5):941-954. doi: 10.1007/s10120-019-00932-0. Epub 2019 Feb 18.
Helicobacter pylori invades the mucosal barrier and infects the mucins of gastric epithelial cells. However, whether gastric carcinogenesis caused by H. pylori infection involves the membrane-bound mucins is unclear. This study explored the role of mucin 17 (MUC17) in gastric cancer (GC) associated with H. pylori infection.
The expression of MUC17 and carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) was examined in human GC cells and tissues with H. pylori infection. Gain- and loss-of-function assays were performed to assess the role of MUC17 in regulating CEACAM1 in H. pylori-infected GC cells.
MUC17 was downregulated in H. pylori-infected GC cells and tissues in association with poor survival of GC patients. Downregulation of MUC17 was attributable to MUC17 promoter methylation mediated by DNA methyltransferase 1 (DNMT1) H. pylori-enhanced GC cell proliferation and colony formation associated with MUC17 downregulation. Gain- and loss-of-function assays showed that MUC17 inhibited the H. pylori-enhanced GC cell growth by preventing the translocation of H. pylori CagA into GC cells. Moreover, MUC17 downregulated the expression of CEACAM1 variant 3S (CEACAM1-3S) in GC cells and tissues with H. pylori infection. Additionally, MUC17 downregulated CEACAM1 promoter activity via attenuation of NF-κB activation in GC cells.
MUC17 was epigenetically downregulated in GC with H. pylori infection. MUC17 inhibited H. pylori CagA translocation via attenuation of NF-κB-mediated expression of CEACAM1-3S in GC cells. Thus, MUC17 may serve as a valuable prognostic biomarker for H. pylori-associated GC.
幽门螺杆菌(H. pylori)侵袭黏膜屏障并感染胃上皮细胞的黏蛋白。然而,H. pylori 感染引起的胃癌(GC)是否涉及膜结合黏蛋白尚不清楚。本研究探讨了黏蛋白 17(MUC17)在与 H. pylori 感染相关的 GC 中的作用。
检测人 GC 细胞和组织中 MUC17 和癌胚抗原相关细胞黏附分子 1(CEACAM1)的表达,通过 gain-和 loss-of-function 实验评估 MUC17 在调节 H. pylori 感染 GC 细胞中 CEACAM1 的作用。
在 H. pylori 感染的 GC 细胞和组织中,MUC17 表达下调,与 GC 患者生存不良相关。MUC17 下调归因于 DNA 甲基转移酶 1(DNMT1)介导的 MUC17 启动子甲基化。H. pylori 增强 GC 细胞增殖和集落形成与 MUC17 下调有关。Gain-和 loss-of-function 实验表明,MUC17 通过阻止 H. pylori CagA 进入 GC 细胞,抑制 H. pylori 增强的 GC 细胞生长。此外,MUC17 下调了 H. pylori 感染的 GC 细胞和组织中 CEACAM1 变体 3S(CEACAM1-3S)的表达。此外,MUC17 通过减弱 NF-κB 激活来下调 GC 细胞中 CEACAM1 启动子活性。
在 H. pylori 感染的 GC 中,MUC17 被表观遗传下调。MUC17 通过减弱 NF-κB 介导的 CEACAM1-3S 表达来抑制 H. pylori CagA 易位。因此,MUC17 可能作为 H. pylori 相关 GC 的有价值的预后生物标志物。